Affinity Capital Management
VC Fund
Minneapolis, United States
Affinity Capital Management is a VC fund in Minneapolis focused on Health Care and Medical Device. Affinity Capital Management offers investment services to firms in the healthcare technology industry. It was founded in 1993 by Edson Spencer and is based in Minnesota.
- Total investments:
- 27
- Last investment:
- Lead investor:
- 19%
Last updated:
For AI agents: llms.txt
Industries Affinity Capital Management invests in
Stages Affinity Capital Management invests in
Countries Affinity Capital Management invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
B. Kristine Johnson
|
|||
|
Edson Spencer
|
|||
3 more contacts available
Investment Focus
Industry
- Health Care 13 (48%)
- Medical Device 9 (33%)
- Medical 6 (22%)
- Biotechnology 5 (19%)
- Therapeutics 4 (15%)
Stage
- Series C 6 (22%)
- Series D 5 (19%)
- Series A 3 (11%)
- Series B 3 (11%)
- Series E 3 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
B. Kristine Johnson
General Partner
|
General Partner | Total investments: 7 | Find email | |
|
Edson Spencer
Founder
|
Founder | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ExplORer Surgical
|
ExplORer Surgical is an interactive surgical playbook that reduces disruptions and wasted disposables by improving surgical team communication. ExplORer Surgical also provides real-time performance and scheduling data to OR administrators to enhance the quality of care and efficiency. Surgical teams use the software to coordinate their activitieswhile managing their tools and supplies in a way never before possible. The result is optimal teamwork, increased efficiency, and high performance.ExplORer Surgical keeps high functioning teams in sync so that physicians can focus on what they do best performing successful procedures that help patients live their best lives. The Explorer provides workflow management through tailored checklists which reduce errors, track efficiency, and eliminate confusion among team members in the OR and procedural suites. It helps medical device companies ease rollout of new devices, saving time and money while improving medical education. | $5M / Series A / Apr 18, 2019 | |
Respicardia
|
Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing patternduring sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™. | $10M / Series D / Sep 04, 2013 | |
|
Respicardia
|
Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing patternduring sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™. | $27M / Series C / Aug 25, 2010 | |
Baxano
|
Baxano, Inc. develops minimally invasive tools to restore spine function and preserve healthy tissue. The company offers iO-Flex System, which targets and decompresses bone and soft tissue in the foramen, lateral recess, and central canal for patients with single and multi-level mild, moderate, and severe stenosis. Its products comprise Neuro Checkdevice that allows the surgeon to confirm that the device is against the bone and the nerve is safely out of the way; MicroBlade ShaverTM instrument, which is used to remove the impinging bone and ligament; Guidewire; probes; and distal handles. The company was founded in 2005 and is based in San Jose, California. | $30M / Series C / Jun 23, 2010 | |
Anulex Technologies
|
Anulex Technologies focus on developing proprietary medical technology to repair and seal the soft tissue of the spine (anulus) for patients undergoing a surgical procedure to remove a herniated disc (discectomy). | $18.3M / Series E / Jun 07, 2010 | |
Hemosphere
|
Hemosphere developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction. | $9.3M / Series A / Apr 07, 2010 | |
ValenTx
|
ValenTx is a development-stage medical device company that focuses on minimally-invasive methods for the treatment of morbid obesity. The company was founded in 2002 and headquartered in Maple Grove, Minnesota. | $22M / Series B / Sep 08, 2009 | |
CoAxia
|
CoAxia is a medical device company that researches therapy and treatment solutions for cerebral ischemia. They are based in Minneapolis, MN. | $21.5M / Series D / Jun 24, 2009 | |
Primaeva Medical
|
Primaeva Medical is a privately held venture capital funded company developing devices for dermatologists, plastic surgeons and other cosmetic/aesthetic physicians. Primaeva Medical is dedicated to providing the aesthetic physician superior new tools for Restoring Youth for their patients who want to reverse the signs of aging. In 2009Primaeva will introduce a groundbreaking fractional radiofrequency system designed for the predictable treatment of aging skin. | $6M / Series C / Feb 21, 2009 | |
|
Respicardia
|
Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing patternduring sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™. | $21M / Series B / Oct 17, 2008 | |
| See all 27 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Affinity Capital Management invest in?
Affinity Capital Management invests primarily in Health Care, Medical Device and Medical startups, most often at Series C and Series D stage. Most of the 27 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Affinity Capital Management?
Public channels for Affinity Capital Management include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Affinity Capital Management?
The team at Affinity Capital Management includes B. Kristine Johnson (General Partner) and Edson Spencer (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
